rs1639122

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001273.5(CHD4):​c.417G>T​(p.Glu139Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 1,554,978 control chromosomes in the GnomAD database, including 133,688 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23964 hom., cov: 27)
Exomes 𝑓: 0.42 ( 109724 hom. )

Consequence

CHD4
NM_001273.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -2.27

Publications

56 publications found
Variant links:
Genes affected
CHD4 (HGNC:1919): (chromodomain helicase DNA binding protein 4) The product of this gene belongs to the SNF2/RAD54 helicase family. It represents the main component of the nucleosome remodeling and deacetylase complex and plays an important role in epigenetic transcriptional repression. Patients with dermatomyositis develop antibodies against this protein. Somatic mutations in this gene are associated with serous endometrial tumors. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
CHD4 Gene-Disease associations (from GenCC):
  • Sifrim-Hitz-Weiss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.4436306E-6).
BP6
Variant 12-6601981-C-A is Benign according to our data. Variant chr12-6601981-C-A is described in ClinVar as Benign. ClinVar VariationId is 1209824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHD4NM_001273.5 linkc.417G>T p.Glu139Asp missense_variant Exon 4 of 40 ENST00000544040.7 NP_001264.2
CHD4NM_001297553.2 linkc.396G>T p.Glu132Asp missense_variant Exon 3 of 39 NP_001284482.1 Q14839F5GWX5
CHD4NM_001363606.2 linkc.417G>T p.Glu139Asp missense_variant Exon 4 of 40 NP_001350535.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHD4ENST00000544040.7 linkc.417G>T p.Glu139Asp missense_variant Exon 4 of 40 5 NM_001273.5 ENSP00000440542.2 Q14839-1
ENSG00000285238ENST00000644480.2 linkn.396G>T non_coding_transcript_exon_variant Exon 4 of 55 ENSP00000493629.2 A0A2R8Y445

Frequencies

GnomAD3 genomes
AF:
0.532
AC:
79635
AN:
149584
Hom.:
23935
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.841
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.408
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.444
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.496
Gnomad MID
AF:
0.268
Gnomad NFE
AF:
0.417
Gnomad OTH
AF:
0.438
GnomAD2 exomes
AF:
0.399
AC:
90088
AN:
226028
AF XY:
0.391
show subpopulations
Gnomad AFR exome
AF:
0.750
Gnomad AMR exome
AF:
0.354
Gnomad ASJ exome
AF:
0.252
Gnomad EAS exome
AF:
0.401
Gnomad FIN exome
AF:
0.462
Gnomad NFE exome
AF:
0.379
Gnomad OTH exome
AF:
0.371
GnomAD4 exome
AF:
0.421
AC:
591468
AN:
1405284
Hom.:
109724
Cov.:
40
AF XY:
0.418
AC XY:
292562
AN XY:
700040
show subpopulations
African (AFR)
AF:
0.781
AC:
25291
AN:
32390
American (AMR)
AF:
0.373
AC:
16215
AN:
43476
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
6621
AN:
25116
East Asian (EAS)
AF:
0.414
AC:
16076
AN:
38792
South Asian (SAS)
AF:
0.402
AC:
33637
AN:
83676
European-Finnish (FIN)
AF:
0.482
AC:
21163
AN:
43880
Middle Eastern (MID)
AF:
0.276
AC:
1542
AN:
5594
European-Non Finnish (NFE)
AF:
0.416
AC:
446253
AN:
1073998
Other (OTH)
AF:
0.423
AC:
24670
AN:
58362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
18548
37096
55643
74191
92739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14492
28984
43476
57968
72460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.533
AC:
79725
AN:
149694
Hom.:
23964
Cov.:
27
AF XY:
0.529
AC XY:
38651
AN XY:
73000
show subpopulations
African (AFR)
AF:
0.840
AC:
34023
AN:
40482
American (AMR)
AF:
0.407
AC:
6130
AN:
15054
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
930
AN:
3462
East Asian (EAS)
AF:
0.444
AC:
2244
AN:
5054
South Asian (SAS)
AF:
0.410
AC:
1941
AN:
4730
European-Finnish (FIN)
AF:
0.496
AC:
5048
AN:
10174
Middle Eastern (MID)
AF:
0.271
AC:
79
AN:
292
European-Non Finnish (NFE)
AF:
0.417
AC:
28097
AN:
67456
Other (OTH)
AF:
0.440
AC:
918
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
1440
2881
4321
5762
7202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.435
Hom.:
54444
Bravo
AF:
0.541
TwinsUK
AF:
0.442
AC:
1640
ALSPAC
AF:
0.444
AC:
1711
ESP6500AA
AF:
0.826
AC:
3616
ESP6500EA
AF:
0.407
AC:
3488
ExAC
AF:
0.421
AC:
50316
Asia WGS
AF:
0.495
AC:
1719
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sifrim-Hitz-Weiss syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thalidomide response Other:1
-
Rare Diseases Genetics and Genomics, Islamia College Peshawar
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

this variant was associated with excellent response to thalidomide (achieving transfusion independence) excellent responsive

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
0.0010
DANN
Benign
0.12
DEOGEN2
Benign
0.0074
.;T;.;T;.;.;.;.;.;.;.;T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.075
N
LIST_S2
Benign
0.39
T;T;T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0000024
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-0.37
.;.;.;N;.;.;.;.;N;.;.;.
PhyloP100
-2.3
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.95
N;N;.;.;.;.;.;.;.;.;.;N
REVEL
Benign
0.22
Sift
Benign
1.0
T;T;.;.;.;.;.;.;.;.;.;T
Sift4G
Benign
0.72
T;T;.;.;.;.;.;.;.;.;.;T
Polyphen
0.0
.;.;B;B;.;.;.;.;B;.;.;.
Vest4
0.10
MutPred
0.12
Loss of stability (P = 0.1508);.;.;Loss of stability (P = 0.1508);.;.;.;Loss of stability (P = 0.1508);Loss of stability (P = 0.1508);Loss of stability (P = 0.1508);.;Loss of stability (P = 0.1508);
MPC
0.0082
ClinPred
0.0026
T
GERP RS
-8.2
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
3.7
Varity_R
0.020
gMVP
0.33
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1639122; hg19: chr12-6711147; COSMIC: COSV58895130; COSMIC: COSV58895130; API